Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.

about

Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter?Flow injection/sequential injection analysis systems: potential use as tools for rapid liver diseases biomarker study.

P2860

Q36815034-8890711C-E48E-4392-837D-C156482FF227 Q41978670-40DDBE50-7D59-4006-AC4E-77B2CB2FF3C2

P2860

Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.

Item

http://www.wikidata.org/entity/Q37477801

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Clinical Benefits of Biochemic ...... n With Chronic Liver Diseases.

@en

Clinical Benefits of Biochemic ...... n With Chronic Liver Diseases.

@nl

type

Item

label

Clinical Benefits of Biochemic ...... n With Chronic Liver Diseases.

@en

Clinical Benefits of Biochemic ...... n With Chronic Liver Diseases.

@nl

prefLabel

Clinical Benefits of Biochemic ...... n With Chronic Liver Diseases.

@en

Clinical Benefits of Biochemic ...... n With Chronic Liver Diseases.

@nl

P1476

Clinical Benefits of Biochemic ...... en With Chronic Liver Diseases

@en

P2093

Azza Abd El-Shaheed

http://www.w3.org/2001/XMLSchema#string

Behairy E Behairy

http://www.w3.org/2001/XMLSchema#string

Karam Mahdy

http://www.w3.org/2001/XMLSchema#string

Mohamed El-Batanony

http://www.w3.org/2001/XMLSchema#string

Mohsen H Hussein

http://www.w3.org/2001/XMLSchema#string

Tawhida Y Abdel-Ghaffar

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular and molecular mechanisms of fibrosis

A new nomenclature for the laminins

Histological grading and staging of chronic hepatitis

Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

Non invasive evaluation of liver fibrosis in paediatric patients with nonalcoholic steatohepatitis.

Transforming growth factor beta and the liver.

Hepatic fibrosis--role of hepatic stellate cell activation.

Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection

Treatment of cirrhotic patients in the pegylated interferon era.

P304

262-271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4021/GR246W

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mostafa Mohamed Sira

P577

2010-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232697179

http://www.w3.org/2001/XMLSchema#string

P698

27942306

http://www.w3.org/2001/XMLSchema#string

P932

5139854

http://www.w3.org/2001/XMLSchema#string

Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.

about

P2860

P2860

Clinical Benefits of Biochemical Markers of Fibrosis in Egyptian Children With Chronic Liver Diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932